Clinical trials
Completed Phase 3 Primary Myelofibrosis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 3 |
| 2002 | 1 |
| 2005 | 2 |
| 2007 | 2 |
| 2008 | 5 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 32 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 4 |
| Fred Hutchinson Cancer Center | 3 |
| Sierra Oncology LLC - a GSK company | 3 |
| Alliance for Clinical Trials in Oncology | 2 |
| Celgene | 2 |
| Memorial Sloan Kettering Cancer Center | 2 |
| Vanderbilt-Ingram Cancer Center | 2 |
| AbbVie | 1 |
| Case Comprehensive Cancer Center | 1 |
| Dartmouth-Hitchcock Medical Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Primary Myelofibrosis | 32 |
| Burkitt Lymphoma | 18 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 18 |
| Leukemia, Myeloid, Accelerated Phase | 18 |
| Leukemia, Myeloid, Chronic-Phase | 18 |
| Lymphoma, Non-Hodgkin | 18 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 18 |
| Blast Crisis | 17 |
| Hodgkin Disease | 17 |
| Lymphoma, B-Cell, Marginal Zone | 17 |
Trials
Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.